Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.07 | 13.44 |
| PEG Ratio (TTM) | -9.80 | -8.72 |
| P/S Ratio (TTM) | 2.70 | 2.41 |
| P/B Ratio (TTM) | 1.19 | 1.43 |
| P/FCF Ratio (TTM) | 9.62 | -0.14 |
| Price to 5YR AVG Earnings Ratio | 16.85 | 22.17 |
| Price to 5YR AVG FCF Ratio | 16.85 | 16.73 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.94% | 0.93% |
| ROE (TTM) | 9.96% | 11.16% |
| Net Profit Margin (TTM) | 22.24% | 19.13% |
| ROIC 5YR AVG | 8.42% | 18.90% |
Growth (40%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.73% | 319.46% | 195.17% |
| Revenue | -1.87% | -2.67% | -0.41% |
| Net Income | 1.06% | 345.00% | 207.37% |
| Cash Flow | -2.74% | -270.93% | -85.78% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.29 | 1.60 |
| Quick Ratio (TTM) | 0.29 | 1.82 |
| D/E Ratio (TTM) | 1.60 | 2.32 |
| Interest Coverage (TTM) | 0.78 | 0.66 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 0.15 | 0.33 |
| LTL to 5YR AVG FCF | 15.93 | 13.84 |
| Shares Outstanding Growth 5YR AVG | -5.10% | -1.24% |